Varicella-zoster virus (strain Oka vaccine) Envelope glycoprotein E Protein (VZV-VM10E)

Produktübersicht

• Artikelname: Varicella-zoster virus (strain Oka vaccine) Envelope glycoprotein E Protein (VZV-VM10E)
• Artikelnummer: KAB-VZV-VM10E
• Hersteller Artikelnummer: VZV-VM10E
• Alternativnummer: KAB-VZV-VM10E-100UG, KAB-VZV-VM10E-500UG
• Hersteller: KactusBio
• Kategorie: Proteine/Peptide
• Spezies Reaktivität: Virus
• Alternative Synonym: Envelope glycoprotein E, gE, ORF68,

Produktbeschreibung

Recombinant Varicella-zoster virus (strain Oka vaccine) Envelope glycoprotein E Protein is expressed from HEK293 with His tag at the C-terminus.It contains Ser31-Tyr538.

Produkteigenschaften

• Molekulargewicht: The protein has a predicted MW of 58.39 kDa. Due to glycosylation, the protein migrates to 65-85 kDa based on Bis-Tris PAGE result.
• Tag: C-His
• UniProt: Q9J3M8
• Puffer: Lyophilized from 0.22 µm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
• Expression System: HEK293
• Reinheit: > 95% as determined by Bis-Tris PAGE,> 95% as determined by HPLC
• Formulierung: Lyophilized
• Sequenz: Ser31-Tyr538
• Target-Kategorie: Envelope glycoprotein E

Bilder

The purity of Varicella-zoster virus (strain Oka vaccine) Envelope glycoprotein E is greater than 95% as determined by SEC-HPLC.

Varicella-zoster virus (strain Oka vaccine) Envelope glycoprotein E on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.